Chemoinformaics analysis of 4-Hydroxy-7-methyl-1-indanone
| Molecular Weight | 162.188 | nRot | 0 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 11 |
| Exact Molecular Weight | 162.068 | nRing | 2 |
| Solubility: LogS | -2.474 | nHRing | 0 |
| Solubility: LogP | 2.158 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 24.9719 |
| nHD | 1 | BPOL | 10.9001 |
| QED | 0.631 |
| Synth | 2.338 |
| Natural Product Likeliness | 1.266 |
| NR-PPAR-gamma | 0.776 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.004 |
| HIA | 0.008 |
| CACO-2 | -4.615 |
| MDCK | 0.0000219 |
| BBB | 0.965 |
| PPB | 0.598239 |
| VDSS | 1.116 |
| FU | 0.356239 |
| CYP1A2-inh | 0.902 |
| CYP1A2-sub | 0.926 |
| CYP2c19-inh | 0.361 |
| CYP2c19-sub | 0.264 |
| CYP2c9-inh | 0.228 |
| CYP2c9-sub | 0.815 |
| CYP2d6-inh | 0.42 |
| CYP2d6-sub | 0.863 |
| CYP3a4-inh | 0.165 |
| CYP3a4-sub | 0.249 |
| CL | 11.416 |
| T12 | 0.713 |
| hERG | 0.024 |
| Ames | 0.759 |
| ROA | 0.839 |
| SkinSen | 0.633 |
| Carcinogencity | 0.849 |
| EI | 0.967 |
| Respiratory | 0.747 |
| NR-Aromatase | 0.041 |
| Antiviral | No |
| Prediction | 0.875222 |